Berlin: (hib/PK) Due to the genetic variability of the coronavirus, vaccines are adapted to the virus variants. Since May 2023, the virus variant XBB.1 and its sublineages have dominated the world. Since September 18, 2023, a Covid-19 vaccine adapted to the Fraction. The Standing Vaccination Commission (Stiko) recommends that variant-adapted vaccines be given preference.
As can be seen from the answer, at the beginning of December 2023 the federal government still had 52.3 million doses of the vaccines that were not adapted to the Omicron XBB.1.5 sub-variant, including 50.7 million doses of Comirnaty (Biontech/Pfizer) and 1.6 million doses of Spikevax (Modern). According to the information, a total of around 132 million doses of vaccine from various manufacturers that were not adapted to the Omicron XBB.1.5 sub-variant were disposed of last year.